activity
20172026
most citedDeep Reinforcement Learning for De-Novo Drug Design

1.2k citations · 1.2k across the 9 of their papers we have counts for

collaborators

10 papers

cs.AI2026

A Modular Agentic Framework for Synthetically Constrained Multi-Objective Hit-to-Lead Optimization

Kelvin P. Idanwekhai, Enes Kelestemur, Benjamin Strickland +6

Hit-to-lead optimization requires iterative design of hit analogs across competing potency, selectivity, physicochemical, pharmacokinetic, safety, and synthetic constraints. We pre…

cs.LG2026

BASIL: Bayesian Application for Scientific Iteration and Learning

Kelvin P. Idanwekhai, Valeriia Kaneva, Stefano Menegatti +1

We introduce BASIL, a user-friendly desktop application for process optimization. BASIL employs a Bayesian approach, incorporating special acquisition functions that can be used to…

physics.chem-ph2026

KANEL: Kolmogorov-Arnold Network Ensemble Learning Enables Early Hit Enrichment in High-Throughput Virtual Screening

Pavel Koptev, Nikita Krainov, Konstantin Malkov +1

Machine learning models of chemical bioactivity are increasingly used for prioritizing a small number of compounds in virtual screening libraries for experimental follow-up. In the…

q-bio.QM2026

Binding Free Energies without Alchemy

Michael Brocidiacono, Brandon Novy, Rishabh Dey +2

Absolute Binding Free Energy (ABFE) methods are among the most accurate computational techniques for predicting protein-ligand binding affinities, but their utility is limited by t…

physics.chem-ph2025

Extending machine learning model for implicit solvation to free energy calculations

Rishabh Dey, Michael Brocidiacono, Kushal Koirala +2

The implicit solvent approach offers a computationally efficient framework to model solvation effects in molecular simulations. However, its accuracy often falls short compared to…

q-bio.QM2025★ 3 cited

Look mom, no experimental data! Learning to score protein-ligand interactions from simulations

Michael Brocidiacono, James Wellnitz, Konstantin I. Popov +1

Despite recent advances in protein-ligand structure prediction, deep learning methods remain limited in their ability to accurately predict binding affinities, particularly for nov…

cs.LG2024

Reliable OOD Virtual Screening with Extrapolatory Pseudo-Label Matching

Yunni Qu, Bhargav Vaduri, Karthikeya Jatoth +6

Machine learning (ML) models are increasingly deployed for virtual screening in drug discovery, where the goal is to identify novel, chemically diverse scaffolds while minimizing e…

q-bio.QM2024★ 1 cited

An Improved Metric and Benchmark for Assessing the Performance of Virtual Screening Models

Michael Brocidiacono, Konstantin I. Popov, Alexander Tropsha

Structure-based virtual screening (SBVS) is a key workflow in computational drug discovery. SBVS models are assessed by measuring the enrichment of known active molecules over deco…

cs.IR2024★ 1 cited

Utilizing Low-Dimensional Molecular Embeddings for Rapid Chemical Similarity Search

Kathryn E. Kirchoff, James Wellnitz, Joshua E. Hochuli +4

Nearest neighbor-based similarity searching is a common task in chemistry, with notable use cases in drug discovery. Yet, some of the most commonly used approaches for this task st…

cs.AI2017★ 1.2k cited

Deep Reinforcement Learning for De-Novo Drug Design

Mariya Popova, Olexandr Isayev, Alexander Tropsha

We propose a novel computational strategy for de novo design of molecules with desired properties termed ReLeaSE (Reinforcement Learning for Structural Evolution). Based on deep an…